Recombinant human neuregulin-1β is protective against radiation-induced myocardial cell injury

5Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

The aim of the present study was to investigate the role of recombinant human neuregulin-1β (rhNRG-1β) in the repair of the radiation-induced damage of myocardial cells and the underlying mechanism. Rats were divided into the radiotherapy alone group, the rhNRG-1β group (radiotherapy with rhNRG-1β treatment) and the Herceptin group (radiotherapy with Herceptin treatment), and their myocardial cells were analyzed. The morphology of the myocardial cells was observed under an optical microscope, and the expression of γ-H2AX and p53 was analyzed using immunohistochemistry and western blot analysis. Damage to the myocardial cells was identified in the three groups following radiation treatment, which was identified by cell swelling and altered morphology. The integrated optical density values of γ-H2AX in the radiotherapy alone, rhNRG-1β and Herceptin groups were 50.96±5.548, 27.63±10.61 and 76.12±2.084, respectively. The OD of the radiotherapy alone group was significantly higher than that of the rhNRG-1β treated group (P

Cite

CITATION STYLE

APA

Zhou, Q., Hu, W., Fei, X., Huang, X., Chen, X., Zhao, D., … Wang, G. (2016). Recombinant human neuregulin-1β is protective against radiation-induced myocardial cell injury. Molecular Medicine Reports, 14(1), 325–330. https://doi.org/10.3892/mmr.2016.5207

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free